Please assess the completion status of the following clinical trial:

Trial Title: Early Versus Late Resumption of Anticoagulation in Patients With Both High Thrombosis Risk and Major HEmoRrhage

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:affiliated with or a beneficiary of a social security category~* age \> 18 years old~* with major bleeding (ISTH) and highs thrombosis risk (ACCP 2008)~* having signed the inform consent form~Exclusion Criteria:~* intracranial bleeding~* artificial heart valves~* bleeding with hemostatic surgical~* low and moderate thrombosis risk~* INR\>1.2~* hemodynamic instability contra-indication to HBPM or HNF treatment~* With previous history of HIT (heparin Inducted thrombopenia)~* patient who need antiaggregant treatment before anticoagulant treatment~* Hæmoglobin count \< 8 g/dl or patients with hæmoglobin count \< 10 g/dl combined with acute coronary syndrome or proven heart failure~* pregnant~* Polytraumatism~* with curatif heparin before randomisation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- UFH Early group (Type: EXPERIMENTAL): anticoagulant (UFH or LMWH) reintroduction at 48h to 72h after hemorrhage
- UFH Late group (Type: ACTIVE_COMPARATOR): anticoagulant (UFH or LMWH) réintroduction 120h to 144h after hemorrhage

Based on this trial design, predict the completion outcome and termination type (if applicable).